The effect of multi‐factorial intervention on plasma von Willebrand factor, soluble E‐selectin and tissue factor in diabetes mellitus: implications for atherosclerotic vascular disease
- 16 February 2005
- journal article
- Published by Wiley in Diabetic Medicine
- Vol. 22 (3) , 249-255
- https://doi.org/10.1111/j.1464-5491.2004.01388.x
Abstract
Background Endothelial abnormalities and a hypercoagulable state may contribute to increased cardiovascular risk in diabetes mellitus, particularly in patients with overt cardiovascular disease (CVD). We sought to determine the effect of intensified multi‐factorial cardiovascular risk intervention on indices of endothelial abnormality and hypercoagulability in diabetes, and if patients with overt CVD would derive similar benefit as those without. Patients and methods We measured plasma von Willebrand factor (vWf, an index of endothelial damage/dysfunction), soluble E‐selectin (sE‐sel, marking endothelial activation) and tissue factor (TF, an initiator of coagulation) by ELISA in 94 patients with diabetes mellitus (38 with CVD and 56 without overt CVD) and 34 comparable controls. Thirty‐three patients with CVD and 31 without overt CVD then participated in multi‐factorial cardiovascular risk intervention over 1 year. Results Plasma levels of vWf (P = 0.009), sE‐sel (P < 0.001) and TF (P < 0.001) were significantly higher in diabetic patients compared with controls, with TF highest in patients with overt CVD. Intensive multi‐factorial intervention resulted in reductions in glycated haemoglobin (HbA1c), total and LDL‐cholesterol (all P < 0.05), but no significant weight change. This was associated with reductions in vWf in patients with (by 26%P = 0.003), and without (by 47%, P < 0.001), overt CVD. TF was reduced only in patients without overt CVD (by 45%, P < 0.001). There were no significant changes in sE‐sel levels in either group. Conclusion Endothelial abnormalities in diabetes are only partially influenced by contemporary intensified multi‐factorial cardiovascular risk intervention. These data suggest the need for earlier and more aggressive risk factor intervention.Keywords
This publication has 36 references indexed in Scilit:
- CONSORT statement: extension to cluster randomised trialsBMJ, 2004
- Low Insulin Sensitivity (Si = 0) in Diabetic and Nondiabetic Subjects in the Insulin Resistance Atherosclerosis StudyDiabetes Care, 2003
- Management of Dyslipidemia in Adults With DiabetesDiabetes Care, 2003
- Standards of Medical Care for Patients With Diabetes MellitusDiabetes Care, 2003
- The Influences of Obesity and Glycemic Control on Endothelial Activation in Patients with Type 2 DiabetesJournal of Clinical Endocrinology & Metabolism, 2001
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- von Willebrand Factor, C-Reactive Protein, and 5-Year Mortality in Diabetic and Nondiabetic SubjectsArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Tissue factor antigen is elevated in patients with microvascular complications of diabetes mellitusExperimental and Clinical Endocrinology & Diabetes, 1997
- Relationship between lactate dehydrogenase and myeloperoxidase levels in human gingival crevicular fluid and clinical and microbial measurementsJournal of Clinical Periodontology, 1988